Definitive radiotherapy for cervical esophageal cancer
Background.The role of contemporary radiotherapy (RT) has not yet been elucidated, mainly because of the low incidence of cervical esophageal cancer.The purpose of this study was to analyze the outcome in patients with cervical esophageal cancer treated with definitive RT.Methods.A total of 115 patients with cervical esophageal cancer treated with definitive RT during January 2001 through April 2012 in our center were analyzed.Eighty patients received RT alone and 35 patients received concurrent chemoradiotherapy with cisplatin administered either weekly (30 mg/m2) or every 3 weeks (80 mg/m2).Results.The median follow-up time was 17.1 months.For all patients,the overall 2-year local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), and overall survival (OS) rate was 68.3%, 83.3%, 75.7%, and 47.6%, respectively.Conclusion.Definitive RT accomplished a satisfactory local control rate and contributed to organ preservation for patients with cervical esophageal cancer.
cervical esophageal cancer treatment radiotherapy survival organ preservationn
Caineng Cao Jingwei Luo Li Gao Guozhen Xu Junlin Yi Xiaodong Huang Kai Wang Shiping Zhang Yuan Qu Suyan Li Jianping Xiao Zhong Zhang
Department of Radiation Oncology,Cancer Hospital,Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC),Beijing,People”s Republic of China
国内会议
北京
英文
450-454
2016-01-09(万方平台首次上网日期,不代表论文的发表时间)